Clinical Trial Update: Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)

View source ↗

Summary

The prospective evaluation trial of radiofrequency ablation using the HALO Ultra device for gastric antral vascular ectasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Antral Vascular Ectasia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Gastric Antral Vascular Ectasia | Status: WITHDRAWN